Plant-based solutions for veterinary immunotherapeutics and prophylactics

Veterinary Research

Volumn 45, Issue 1, 2014, Pages

  Kolotilin, Igor ^a   Topp, Ed ^b   Cox, Eric ^c   Devriendt, Bert ^c   Conrad, Udo ^d   Joensuu, Jussi ^e   Stöger, Eva ^f   Warzecha, Heribert ^g   McAllister, Tim ^b   Potter, Andrew ^h,i   McLean, Michael D ^j   Hall, J Christopher ^j   Menassa, Rima ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b AGRICULTURE AND AGRI FOOD CANADA   (Canada)

^c GHENT UNIVERSITY   (Belgium)

^d LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

^e VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^f UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^g DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^h UNIVERSITY OF SASKATCHEWAN   (Canada)

ⁱ UNIVERSITY OF SASKATCHEWAN   (Canada)

^j UNIVERSITY OF GUELPH   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; RECOMBINANT PROTEIN; VACCINE;

ANIMAL; BIOSYNTHESIS; BIOTECHNOLOGY; DRUG DELIVERY SYSTEM; ECONOMICS; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; LIVESTOCK; METABOLISM; TRANSGENIC PLANT; VETERINARY;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOTECHNOLOGY; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; LIVESTOCK; PLANTS, GENETICALLY MODIFIED; RECOMBINANT PROTEINS; VACCINES;

EID: 84924025414     PISSN: 09284249     EISSN: 12979716     Source Type: Journal    
DOI: 10.1186/s13567-014-0117-4     Document Type: Review

References (100)

1. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL, Jones JL, Griffin PM: Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis 2011, 17:7-15.
2. One Health Initiative: One Health Initiative will unite human and veterinary medicine. 2014. [http://www.onehealthinitiative.com/index.php] (accessed 2014/08/29).
3. Potter A, Gerdts V, Litte-van den Hurk S: Veterinary vaccines: alternatives to antibiotics? Anim Health Res Rev 2008, 9:187-199.
4. Research and Markets: Animal/Veterinary Vaccines Market by Products, Diseases & Technology - Global Forecast to 2018. 2013. [http://www.researchandmarkets.com/research/gcksr4/animalveterinary] (accessed 2014/08/29).
5. Chappuis G: Neonatal immunity and immunisation in early age: lessons from veterinary medicine. Vaccine 1998, 16:1468-1472.
6. Sangild PT: Uptake of colostral immunoglobulins by the compromised newborn farm animal. Acta Vet Scand Suppl 2003, 98:105-122.
7. Hurley WL, Theil PK: Perspectives on immunoglobulins in colostrum and milk. Nutrients 2011, 3:442-474.
8. Cervenak J, Kacskovics I: The neonatal Fc receptor plays a crucial role in the metabolism of IgG in livestock animals. Vet Immunol Immunopathol 2009, 128:171-177.
9. Mayer B, Kis Z, Kajan G, Frenyo LV, Hammarstrom L, Kacskovics I: The neonatal Fc receptor (FcRn) is expressed in the bovine lung. Vet Immunol Immunopathol 2004, 98:85-89.
10. Porter P, Noakes DE, Allen WD: Secretory IgA and antibodies to Escherichia coli in porcine colostrum and milk and their significance in the alimentary tract of the young pig. Immunology 1970, 18:245-257.
11. Brandtzaeg P: Secretory immunity with special reference to the oral cavity. J Oral Microbiol 2013, 5:20401.
12. Snoeck V, Peters IR, Cox E: The IgA system: a comparison of structure and function in different species. Vet Res 2006, 37:455-467.
13. Holmgren J, Czerkinsky C: Mucosal immunity and vaccines. Nat Med 2005, 11:S45-S53.
14. Devriendt B, De Geest BG, Goddeeris BM, Cox E: Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery. J Control Release 2012, 160: 431-439.
15. Holmgren J, Svennerholm AM: Vaccines against mucosal infections. Curr Opin Immunol 2012, 24:343-353.
16. Cox E, Verdonck F, Vanrompay D, Goddeeris B: Adjuvants modulating mucosal immune responses or directing systemic responses towards the mucosa. Vet Res 2006, 37:511-539.
17. Van den Broeck W, Cox E, Goddeeris BM: Receptor-dependent immune responses in pigs after oral immunization with F4 fimbriae. Infect Immun 1999, 67:520-526.
18. Snoeck V, Van den Broeck W, De Colvenaer V, Verdonck F, Goddeeris B, Cox E: Transcytosis of F4 fimbriae by villous and dome epithelia in F4-receptor positive pigs supports importance of receptor-dependent endocytosis in oral immunization strategies. Vet Immunol Immunopathol 2008, 124:29-40.
19. Boleman SL, Boleman SJ, Morgan WW, Hale DS, Griffin DB, Savell JW, Ames RP, Smith MT, Tatum JD, Field TG, Smith GC, Gardner BA, Morgan JB, Northcutt SL, Dolezal HG, Gill DR, Ray FK: National Beef Quality Audit-1995: survey of producer-related defects and carcass quality and quantity attributes. J Anim Sci 1998, 76:96-103.
20. Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B: Vaccine adjuvants: current challenges and future approaches. J Pharm Sci 2009, 98:1278-1316.
21. Lawhorn DB: Atrophic rhinitis. In Texas A&M AgriLife Extension Service. 2002. [http://hdl.handle.net/1969.1/87644]. (accessed 2014/10/28).
22. Garlapati S, Eng NF, Kiros T, Kindrachuk J, Mutwiri G, Hancock RE, Potter A, Babiuk LA, Gerdts V: Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induce protective immunity against pertussis. Vaccine 2011, 29:6540-6548.
23. Polewicz M, Gracia A, Garlapati S, van Kessel J, Strom S, Halperin S, Hancock RE, Potter A, Babiuk LA, Gerdts V: Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine 2013, 31:3148-3155.
24. Lycke N: Recent progress in mucosal vaccine development: potential and limitations. Nat Rev Immunol 2012, 12:592-605.
25. Zaman M, Chandrudu S, Toth I: Strategies for intranasal delivery of vaccines. Drug Deliv Transl Res 2013, 3:100-109.
26. Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R: Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 2004, 350:896-903.
27. Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D: Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004, 1:2.
28. Langridge WH: Edible vaccines. Sci Am 2000, 283:66-71.
29. Rybicki EP: Plant-made vaccines for humans and animals. Plant Biotechnol J 2010, 8:620-637.
30. Komarova TV, Baschieri S, Donini M, Marusic C, Benvenuto E, Dorokhov YL: Transient expression systems for plant-derived biopharmaceuticals. Expert Rev Vaccines 2010, 9:859-876.
31. Desai PN, Shrivastava N, Padh H: Production of heterologous proteins in plants: strategies for optimal expression. Biotechnol Adv 2010, 28:427-435.
32. Sharma AK, Sharma MK: Plants as bioreactors: Recent developments and emerging opportunities. Biotechnol Adv 2009, 27:811-832.
33. Bock R, Warzecha H: Solar-powered factories for new vaccines and antibiotics. Trends Biotechnol 2010, 28:246-252.
34. Tregoning JS, Nixon P, Kuroda H, Svab Z, Clare S, Bowe F, Fairweather N, Ytterberg J, van Wijk KJ, Dougan G, Maliga P: Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Res 2003, 31:1174-1179.
35. D'Aoust M, Couture MM, Charland N, Trépanier S, Landry N, Ors F, Vézina L: The production of hemagglutinin-based virus-like particles in plants: a rapid, efficient and safe response to pandemic influenza. Plant Biotechnol J 2010, 8:607-619.
36. Gleba Y, Klimyuk V, Marillonnet S: Viral vectors for the expression of proteins in plants. Curr Opin Biotechnol 2007, 18:134-141.
37. Medicago Inc: 2014. [http://www.medicago.com/English/Home/default.aspx] (accessed 2014/08/29).
38. Kentucky Bioprocessing LLC: 2014. [http://www.kbpllc.com/] (accessed 2014/08/29).
39. Werner S, Breus O, Symonenko Y, Marillonnet S, Gleba Y: High-level recombinant protein expression in transgenic plants by using a doubleinducible viral vector. Proc Natl Acad Sci U S A 2011, 108:14061-14066.
40. Xu J, Ge X, Dolan MC: Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol Adv 2011, 29:278-299.
41. Walsh G: Post-translational modifications of protein biopharmaceuticals. Drug Discov Today 2010, 15:773-780.
42. Aviezer D, Brill-Almon E, Shaaltiel Y, Hashmueli S, Bartfeld D, Mizrachi S, Liberman Y, Freeman A, Zimran A, Galun E: A plant-derived recombinant human glucocerebrosidase enzyme - a preclinical and phase I investigation. PLoS One 2009, 4:e4792.
43. Peters J, Stoger E: Transgenic crops for the production of recombinant vaccines and anti-microbial antibodies. Hum Vaccin 2011, 7: 367-374.
44. Stoger E, Ma JK, Fischer R, Christou P: Sowing the seeds of success: pharmaceutical proteins from plants. Curr Opin Biotechnol 2005, 16:167-173.
45. Lakshmi PS, Verma D, Yang X, Lloyd B, Daniell H: Low cost tuberculosis vaccine antigens in capsules: expression in chloroplasts, bioencapsulation, stability and functional evaluation in vitro. PLoS One 2013, 8:e54708.
46. Joensuu JJ, Verdonck F, Ehrstrom A, Peltola M, Siljander-Rasi H, Nuutila AM, Oksman-Caldentey KM, Teeri TH, Cox E, Goddeeris BM, Niklander-Teeri V: F4 (K88) fimbrial adhesin FaeG expressed in alfalfa reduces F4+ enterotoxigenic Escherichia coli excretion in weaned piglets. Vaccine 2006, 24:2387-2394.
47. Wilken LR, Nikolov ZL: Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 2012, 30:419-433.
48. Jacob SS, Cherian S, Sumithra TG, Raina OK, Sankar M: Edible vaccines against veterinary parasitic diseases-current status and future prospects. Vaccine 2013, 31:1879-1885.
49. Streatfield SJ: Plant-based vaccines for animal health. Rev Sci Tech 2005, 24:189-199.
50. Phan HT, Hause B, Hause G, Arcalis E, Stoger E, Maresch D, Altmann F, Joensuu J, Conrad U: Influence of elastin-like polypeptide and hydrophobin on recombinant hemagglutinin accumulations in transgenic tobacco plants. PLoS One 2014, 9:e99347.
51. Gomord V, Fitchette AC, Menu-Bouaouiche L, Saint-Jore-Dupas C, Plasson C, Michaud D, Faye L: Plant-specific glycosylation patterns in the context of therapeutic protein production. Plant Biotechnol J 2010, 8: 564-587.
52. Hofbauer A, Stoger E: Subcellular accumulation and modification of pharmaceutical proteins in different plant tissues. Curr Pharm Des 2013, 19:5495-5502.
53. Bosch D, Castilho A, Loos A, Schots A, Steinkellner H: N-glycosylation of plant-produced recombinant proteins. Curr Pharm Des 2013, 19:5503-5512.
54. Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, Futerman AH, Aviezer D: Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system. Plant Biotechnol J 2007, 5:579-590.
55. Castilho A, Strasser R, Stadlmann J, Grass J, Jez J, Gattinger P, Kunert R, Quendler H, Pabst M, Leonard R, Altmann F, Steinkellner H: In planta protein sialylation through overexpression of the respective mammalian pathway. J Biol Chem 2010, 285:15923-15930.
56. Gasdaska JR, Sherwood S, Regan JT, Dickey LF: An afucosylated anti-CD20 monoclonal antibody with greater antibody-dependent cellular cytotoxicity and B-cell depletion and lower complement-dependent cytotoxicity than rituximab. Mol Immunol 2012, 50:134-141.
57. Yang Z, Drew DP, Jorgensen B, Mandel U, Bach SS, Ulvskov P, Levery SB, Bennett EP, Clausen H, Petersen BL: Engineering mammalian mucin-type O-glycosylation in plants. J Biol Chem 2012, 287:11911-11923.
58. Takaiwa F: Update on the use of transgenic rice seeds in oral immunotherapy. Immunotherapy 2013, 5:301-312.
59. Khan I, Twyman RM, Arcalis E, Stoger E: Using storage organelles for the accumulation and encapsulation of recombinant proteins. Biotechol J 2012, 7:1099-1108.
60. Zimmermann J, Saalbach I, Jahn D, Giersberg M, Haehnel S, Wedel J, Macek J, Zoufal K, Glunder G, Falkenburg D, Kipriyanov S: Antibody expressing pea seeds as fodder for prevention of gastrointestinal parasitic infections in chickens. BMC Biotechnol 2009, 9:79.
61. Nochi T, Takagi H, Yuki Y, Yang L, Masumura T, Mejima M, Nakanishi U, Matsumura A, Uozumi A, Hiroi T, Morita S, Tanaka K, Takaiwa F, Kiyono H: Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc Natl Acad Sci U S A 2007, 104:10986-10991.
62. Woodleif WG, Chaplin JF, Cambell CR, Dejong DW: Effect of variety and harvest treatments on protein yield of close grown tobacco. Tobacco Sci 1981, 25:83-86.
63. Pogue GP, Vojdani F, Palmer KE, Hiatt E, Hume S, Phelps J, Long L, Bohorova N, Kim D, Pauly M, Velasco J, Whaley K, Zeitlin L, Garger SJ, White E, Bai Y, Haydon H, Bratcher B: Production of pharmaceutical-grade recombinant aprotinin and a monoclonal antibody product using plant-based transient expression systems. Plant Biotechnol J 2010, 8:638-654.
64. Cummings JF, Guerrero ML, Moon JE, Waterman P, Nielsen RK, Jefferson S, Gross FL, Hancock K, Katz JM, Yusibov V, Fraunhofer USACfMBSG: Safety and immunogenicity of a plant-produced recombinant monomer hemagglutinin-based influenza vaccine derived from influenza A (H1N1) pdm09 virus: a Phase 1 dose-escalation study in healthy adults. Vaccine 2014, 32:2251-2259.
65. ICON Genetics GmbH: 2014. [http://www.icongenetics.com/html/home.htm] (accessed 2014/08/29).
66. Melnik S, Stoger E: Green factories for biopharmaceuticals. Curr Med Chem 2013, 20:1038-1046.
67. Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP: Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature 2014, 514:47-53.
68. Lentz EM, Garaicoechea L, Alfano EF, Parreno V, Wigdorovitz A, Bravo-Almonacid FF: Translational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobacco. Planta 2012, 236:703-714.
69. Rodriguez M, Ramirez NI, Ayala M, Freyre F, Perez L, Triguero A, Mateo C, Selman-Housein G, Gavilondo JV, Pujol M: Transient expression in tobacco leaves of an aglycosylated recombinant antibody against the epidermal growth factor receptor. Biotechnol Bioeng 2005, 89:188-194.
70. Zeitlin L, Bohorov O, Bohorova N, Hiatt A, do Kim H, Pauly MH, Velasco J, Whaley KJ, Barnard DL, Bates JT, Crowe JE Jr, Piedra PA, Gilbert BE: Prophylactic and therapeutic testing of Nicotiana-derived RSVneutralizing human monoclonal antibodies in the cotton rat model. MAbs 2013, 5: 263-269.
71. Grohs BM, Niu Y, Veldhuis LJ, Trabelsi S, Garabagi F, Hassell JA, McLean MD, Hall JC: Plant-produced trastuzumab inhibits the growth of HER2 positive cancer cells. J Agric Food Chem 2010, 58:10056-10063.
72. Virdi V, Coddens A, De Buck S, Millet S, Goddeeris BM, Cox E, De Greve H, Depicker A: Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection. Proc Natl Acad Sci U S A 2013, 110:11809-11814.
73. Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P, van Dolleweerd C, Mostov K, Lehner T: Generation and assembly of secretory antibodies in plants. Science 1995, 268:716-719.
74. Corthesy B: Recombinant secretory IgA for immune intervention against mucosal pathogens. Biochem Soc Trans 1997, 25:471-475.
75. Zeltins A: Construction and characterization of virus-like particles: a review. Mol Biotechnol 2013, 53:92-107.
76. Spohn G, Bachmann MF: Exploiting viral properties for the rational design of modern vaccines. Expert Rev Vaccines 2008, 7: 43-54.
77. Mason HS, Lam DM, Arntzen CJ: Expression of hepatitis B surface antigen in transgenic plants. Proc Natl Acad Sci U S A 1992, 89:11745-11749.
78. Greco R, Michel M, Guetard D, Cervantes-Gonzalez M, Pelucchi N, Wain-Hobson S, Sala F, Sala M: Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. Vaccine 2007, 25:8228-8240.
79. Thuenemann EC, Meyers AE, Verwey J, Rybicki EP, Lomonossoff GP: A method for rapid production of heteromultimeric protein complexes in plants: assembly of protective bluetongue virus-like particles. Plant Biotechnol J 2013, 11:839-846.
80. Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS: An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26:1846-1854.
81. Lai H, He J, Engle M, Diamond MS, Chen Q: Robust production of virus-like particles and monoclonal antibodies with geminiviral replicon vectors in lettuce. Plant Biotechnol J 2012, 10:95-104.
82. Vézina L-P, D'Aoust M-A, Landry N, Couture MMJ, Charland N, Ors F, Barbeau B, Sheldon AJ: Plants as an innovative and accelerated vaccine-manufacturing solution. Bio Pharm Int 2011, Santa Monica, CA: Advanstar Communications Inc. S27-S30.
83. Scotti N, Rybicki EP: Plant-produced virus-like particle vaccines. In Virus-like Particles in Vaccine Development. Edited by Buonaguro FM, Buonaguro L. London, UK: Future Medicine Ltd; 2014:102-118.
84. Vermij P: USDA approves the first plant-based vaccine. Nat Biotechnol 2006, 24:233-234.
85. Joensuu JJ, Niklander-Teeri V, Brandle JE: Transgenic plants for animal health: Plant-made vaccine antigens for animal infectious disease control. Phytochem Rev 2008, 7:553-577.
86. Zhou JY, Cheng LQ, Zheng XJ, Wu JX, Shang SB, Wang JY, Chen JG: Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus. J Biotechnol 2004, 111:121-130.
87. Wu J, Yu L, Li L, Hu J, Zhou J, Zhou X: Oral immunization with transgenic rice seeds expressing VP2 protein of infectious bursal disease virus induces protective immune responses in chickens. Plant Biotechnol J 2007, 5:570-578.
88. Gomez E, Lucero MS, Chimeno Zoth S, Carballeda JM, Gravisaco MJ, Berinstein A: Transient expression of VP2 in Nicotiana benthamiana and its use as a plant-based vaccine against infectious bursal disease virus. Vaccine 2013, 31:2623-2627.
89. Lamphear BJ, Jilka JM, Kesl L, Welter M, Howard JA, Streatfield SJ: A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine 2004, 22:2420-2424.
90. Kolotilin I, Kaldis A, Devriendt B, Joensuu J, Cox E, Menassa R: Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco. PLoS One 2012, 7:e42405.
91. Joensuu JJ, Kotiaho M, Teeri TH, Valmu L, Nuutila AM, Oksman-Caldentey KM, Niklander-Teeri V: Glycosylated F4 (K88) fimbrial adhesin FaeG expressed in barley endosperm induces ETEC-neutralizing antibodies in mice. Transgenic Res 2006, 15:359-373.
92. Yang CD, Liao JT, Lai CY, Jong MH, Liang CM, Lin YL, Lin NS, Hsu YH, Liang SM: Induction of protective immunity in swine by recombinant bamboo mosaic virus expressing foot-and-mouth disease virus epitopes. BMC Biotechnol 2007, 7:62.
93. Khandelwal A, Lakshmi Sita G, Shaila MS: Oral immunization of cattle with hemagglutinin protein of rinderpest virus expressed in transgenic peanut induces specific immune responses. Vaccine 2003, 21: 3282-3289.
94. Perez Filgueira DM, Zamorano PI, Dominguez MG, Taboga O, Del Medico Zajac MP, Puntel M, Romera SA, Morris TJ, Borca MV, Sadir AM: Bovine herpes virus gD protein produced in plants using a recombinant tobacco mosaic virus (TMV) vector possesses authentic antigenicity. Vaccine 2003, 21:4201-4209.
95. Aguirreburualde MS, Gomez MC, Ostachuk A, Wolman F, Albanesi G, Pecora A, Odeon A, Ardila F, Escribano JM, Dus Santos MJ, Wigdorovitz A: Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants. Vet Immunol Immunopathol 2013, 151: 315-324.
96. Pastagia M, Schuch R, Fischetti VA, Huang DB: Lysins: the arrival of pathogen-directed anti-infectives. J Med Microbiol 2013, 62:1506-1516.
97. Oey M, Lohse M, Scharff LB, Kreikemeyer B, Bock R: Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proc Natl Acad Sci U S A 2009, 106:6579-6584.
98. Zeitler B, Bernhard A, Meyer H, Sattler M, Koop HU, Lindermayr C: Production of a de-novo designed antimicrobial peptide in Nicotiana benthamiana. Plant Mol Biol 2013, 81:259-272.
99. Lee SB, Li B, Jin S, Daniell H: Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections. Plant Biotechnol J 2011, 9:100-115.
100. Company N, Nadal A, La Paz JL, Martinez S, Rasche S, Schillberg S, Montesinos E, Pla M: The production of recombinant cationic alphahelical antimicrobial peptides in plant cells induces the formation of protein bodies derived from the endoplasmic reticulum. Plant Biotechnol J 2014, 12:81-92.